Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Your search for alhxu.fun returned no results
Showing 1 to 13 of 13 results for alexs

  1. Alectinib for untreated ALK-positive advanced non-small-cell lung cancer (TA536)

    Evidence-based recommendations on alectinib (Alecensa) for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    8 August 2018

    Sections for TA536

  2. Ceritinib for untreated ALK-positive non-small-cell lung cancer (TA500)

    Evidence-based recommendations on ceritinib (Zykadia) for untreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    24 January 2018
    View recommendations

    Sections for TA500

  3. Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor (TA670)

    Evidence-based recommendations on brigatinib (Alunbrig) for anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor.

    Technology appraisal guidance
    Published
    27 January 2021
    View recommendations

    Sections for TA670

  4. Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer (TA909)

    Evidence-based recommendations on lorlatinib (Lorviqua) for untreated ALK-positive advanced non-small-cell lung cancer in adults.

    Technology appraisal guidance
    Published
    12 July 2023
    View recommendations

    Sections for TA909

  5. Diagnostics advisory committee members

    has completed an LLM in Healthcare Ethics and Law. Dr Alex Novak Biography Alex Novak is a Consultant in Emergency Medicine...

  6. NICER Guidance: fostering an organisational culture of evidence-based decision making

    Contact details Name: Alex Weatherley & Dr Badrinath Job:

    Shared learning
    Last updated
    16 April 2015

  7. Best evidence for a better back (BE FABB) - A triage, assessment and education service for patients with low back pain with or without sciatica

    Contact details Name: Alex Porter Job: Deputy Therapy Manager

    Shared learning
    Last updated
    18 November 2020

  8. Preventing excess weight gain (NG7)

    This guideline covers behaviours such as diet and physical activity to help children (after weaning), young people and adults maintain a healthy weight or help prevent excess weight gain. The aim is to prevent a range of diseases and conditions including cardiovascular disease and type 2 diabetes and improve mental wellbeing.

    NICE guideline
    Published
    13 March 2015
    View recommendations

    Sections for NG7

  9. Committee C members

    approved higher qualifications and aiming to complete his MSc soon. Dr Alex Cale Director, MC Healthcare Evaluation Biography to follow....

  10. Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]

    Discontinued [GID-HST10038]

    Highly specialised technologies guidance
    Discontinued

  11. Eteplirsen for treating Duchenne muscular dystrophy [ID1003]

    Discontinued [GID-HST10007]

    Highly specialised technologies guidance
    Discontinued

  12. Idebenone for treating Duchenne muscular dystrophy [ID1092]

    Discontinued [GID-TA10310]

    Technology appraisal guidance
    Discontinued

  13. Guide to the processes of technology appraisal (PMG19)

    Guide to the processes of technology appraisal